INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $138,000 | +3.0% | 13,683 | -26.0% | 0.00% | – |
| Q2 2018 | $134,000 | +21.8% | 18,483 | +1.4% | 0.00% | – |
| Q1 2018 | $110,000 | -63.1% | 18,233 | -41.2% | 0.00% | -100.0% |
| Q4 2017 | $298,000 | +109.9% | 31,008 | +93.5% | 0.00% | – |
| Q3 2017 | $142,000 | -6.6% | 16,026 | +33.5% | 0.00% | – |
| Q2 2017 | $152,000 | +6.3% | 12,002 | -0.9% | 0.00% | – |
| Q3 2016 | $143,000 | -61.9% | 12,116 | -8.1% | 0.00% | -100.0% |
| Q3 2015 | $375,000 | -29.6% | 13,184 | -11.1% | 0.00% | 0.0% |
| Q2 2015 | $533,000 | -15.8% | 14,831 | +36.1% | 0.00% | -33.3% |
| Q1 2015 | $633,000 | -37.1% | 10,896 | -58.0% | 0.00% | -50.0% |
| Q3 2014 | $1,006,000 | +62.0% | 25,940 | +30.5% | 0.01% | +50.0% |
| Q2 2014 | $621,000 | – | 19,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |